# § 520.1782   Pimobendan solution.

(a) *Specifications.* Each milliliter of solution contains 1.5 milligrams (mg) pimobendan.


(b) *Sponsor.* See No. 000010 in § 510.600(c) of this chapter.


(c) *Conditions of use in dogs*—(1) *Amount.* Administer orally at a total daily dose of 0.23 mg/lb (0.5 mg/kg) body weight. The total daily dose should be divided into two equal portions administered approximately 12 hours apart (*i.e.,* morning and evening).


(2) *Indications for use.* For the management of the signs of mild, moderate, or severe congestive heart failure in dogs due to clinical myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM); for use with concurrent therapy for congestive heart failure (*e.g.,* furosemide, etc.) as appropriate on a case-by-case basis.


(3) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.



---

[N] [89 FR 42357, May 15, 2024]






